EIKN

SEC filing EIKN Reports $0 Revenue, -$12.3M Net Loss, +15% YoY Users to 45K

1d ago

News At a glance: stocks gapping up premarket

21d ago

Insider trade Purchase by Column Group IV GP, LP / Column Group IV-A, LP / Column Group IV, LP / Column Group Opportunity III, LP / Column Group Opportunity III GP, LP / TCG Opportunity III GP, LLC / Tim Kutzkey / Peter Svennilson

104d ago

Insider trade Purchase by Lux Venture Partners V, LLC / Josh Wolfe / Peter Hebert / Lux Ventures V, L.P. / Lux Co-Invest Opportunities II, L.P. / Lux Total Opportunities, L.P.

104d ago

Insider trade Purchase by Josh Wolfe

104d ago

Insider trade Purchase by Kenneth C Frazier

104d ago

Insider trade Purchase by Foresite Capital Management IV, LLC / Foresite Capital Fund IV, L.P. / Foresite Capital Management V, LLC / Foresite Capital Fund V, L.P. / Foresite Capital Opportunity Management V, LLC / Foresite Capital Opportunity Fund V, L.P. / Foresite Capital VI-A Management, L

104d ago

News Eikon Therapeutics prices upsized IPO of 21.18M shares at $18.00

117d ago

News Catalyst Watch: Amazon earnings, IPO blitz, gold swings, and the jobs report

122d ago

News Merck veteran-led Eikon seeks $908M valuation in U.S. IPO ‍

124d ago